Decades of Underinvestment. Devastating Outcomes.

Decades of critical underinvestment in gynaecological cancer research have resulted in devastating outcomes for women.

While significant investment in cancer research has been made, over the past 20 years, gynaecological cancers have received some of the poorest funding in aggregate. This sustained underfunding has left survival rates stagnant at levels comparable for all cancers in 1975.

Gynaecological cancers are among the most lethal for women today.

Every day, six women lose their lives to gynaecological cancers — that’s over 2,200 annually.

The crisis is further compounded by stark inequities faced by women in regional, rural and remote areas, those from lower socioeconomic backgrounds, and First Nations women.

These are not just statistics; they are women - our mothers, sisters, daughters, wives, and friends. And the impact extends far beyond the individual, affecting families and communities for generations.

It's time to say ENOUGH! Underfunding in research is costing women with gynaecological cancers their lives.

The Gynaecological Cancer Transformation Initiative (GCTI) is a once-in-a- generation opportunity to revolutionise the diagnosis, treatment and care pathway for women with a gynaecological cancer, to significantly reduce the devastating impact of these diseases and save lives.

To achieve this transformation, a $100 million commitment is sought from the Australian Government over four years

Add your voice. Demand change.

Together, we can save lives.

Add your name today. DEMAND CHANGE.

Dear Prime Minister,

It's time to transform the diagnosis, treatment and care pathway for women with a gynaecological cancer, to save their lives.

With devastatingly low survival rates, treatment resistance, no form of early detection for many, and poor information pathways, gynaecological cancers are most often diagnosed at later stages, when disease is widespread, and recurrence is the norm.

Women and their families are desperate for change and feel they have been overlooked for decades, costing lives and heavily impacting families, the community, women's participation and financial wellbeing, and the economy.

Australia is one of the world's recognised leaders in cancer research, and yet gynaecological cancers are among the most underfunded over the past 20 years.

That is why we urge you to commit to support the Gynaecological Cancer Transformation Initiative with $100 million over 4 years to revolutionise the diagnosis, treatment and care pathway for women with a gynaecological cancer, saving lives.

Thank you for listening to and supporting the women of Australia.

First Name *

Last Name *

Email *

Mobile

By adding your name to this letter, you give permission for ANZGOG WomenCan to contact you with updates on our work. We are committed to the protection of your information. For more information please see our Privacy Policy

Enough is enough.
add your voice. demand change

ADD MY NAME TODAY

A hidden crisis for australian women

Every day, 19 women are diagnosed with a gynaecological cancer in Australia, including uterine, endometrial, ovarian, cervical, vaginal and vulvar cancers. Diagnoses are expected to surge by 21 per cent over the next 10 years.

Over 55 per cent of gynaecological cancers are rare or less common, meaning there are limited or no treatment options. Unlike other cancers and chronic diseases, gynaecological cancers grow silently during the curable stage, so that when detected, the cancer is often advanced and incurable.

ADD MY NAME

About the Gynaecological Cancer transformation initiative

For the first time, leading gynaecological cancer organisations, clinical and pre-clinical researchers, and women with lived experience have joined forces to develop the Gynaecological Cancer Transformation Initiative.

This evidence-based initiative is a once-in-a- generation opportunity to revolutionise the diagnosis, treatment and care pathway for women with a gynaecological cancer, to significantly reduce the devastating impact of these diseases and save lives.

This Gynaecological Cancer Transformation Initiative will bring three key and interdependent areas of focus:

The woman’s journey – equitable access to optimal personalised treatment and improved survival, with specialist supportive care.
The clinical team – delivering timely care that is driven by innovative application of technology, research and data.
The research community – a framework for coordinating and integrating gynaecological cancer research for rapid translation into new treatment solutions (bench to bedside).

The goal is to deliver equitable access to world-class healthcare, improving quality of life and saving the lives of more than 30,000 Australian women with gynaecological cancer over the next decade alone.

Want to know more?

Download our full report for the details.